Beyond Air, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. (NASDAQ: XAIR) on December 8, 2025, reporting an event that occurred on January 13, 2026. The filing discloses a strategic transaction involving the Company's biotechnology subsidiary, NeuroNOS Ltd.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on the terms of a proposed asset sale.
Material Changes and Transaction Details
On January 13, 2026, Beyond Air announced a binding letter of intent with XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) to sell its 85% ownership interest in NeuroNOS Ltd. NeuroNOS is a biotechnology company developing disease-modifying therapeutics for Autism Spectrum Disorder (ASD) and neuro-oncology.
The proposed consideration for the 85% stake includes:
- 19.9% of XTL's issued share capital.
- $1 million in cash.
- Milestone-based contingent payments totaling up to $31.5 million.
Definitive agreements are currently being negotiated and will be filed once available.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the proposed transaction and anticipated definitive agreements. Management notes that actual results may differ materially from expectations. The Company undertakes no obligation to update these statements except as required by law. No specific financial guidance or outlook for the parent company's remaining operations is provided in this filing.
Investor Verification Checklist
- Verify the execution of definitive agreements for the NeuroNOS acquisition by XTL Biopharmaceuticals.
- Confirm the valuation and terms of the 19.9% equity stake in XTL to be received by Beyond Air.
- Review the specific milestones required to trigger the up to $31.5 million in contingent payments.
- Monitor subsequent filings (Form 8-K or Form 10-K) for the final transaction structure and closing date.